Overview


According to FutureWise analysis, the market for Real-world Data (RWD) is expected to grow with a CAGR of 7.4% over the forecast period 2024-2032, and reach a market value of US$ 1.99 Billion by 2031. 

Real-world Data (RWD) refers to health-related information from various sources outside controlled clinical trials. This data is obtained from everyday clinical practice, patient experiences, electronic health records, claims data, and other healthcare systems. Unlike data gathered in controlled environments, RWD reflects the complexities and nuances of real-world healthcare delivery. It encompasses various information, including patient demographics, treatment histories, clinical outcomes, and healthcare resource utilization.  It captures the diverse range of patient experiences, considering factors like comorbidities, treatment adherence, and clinical practice variations. This makes RWD an invaluable resource for assessing medical interventions' effectiveness, safety, and cost-effectiveness in real-world clinical settings.

Researchers, pharmaceutical companies, healthcare providers, and regulatory bodies increasingly recognize the significance of RWD in complementing data derived from clinical trials. It is pivotal in generating real-world evidence (RWE) that informs clinical decision-making, drug development, and healthcare policy. By analyzing RWD, stakeholders gain insights into treatment outcomes, disease progression, and the comparative effectiveness of different interventions. This information is especially vital for evaluating medical treatments' long-term benefits and risks.

FutureWise Market Research has published a report that provides an insightful analysis of Real-world Data (RWD) Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Real-world Data (RWD) Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Anthem, Inc. 
  • IQVIA Holdings Inc.
  • ICON plc 
  • PPD Inc. 
  • Clinigen Group plc  
  • Cognizant Technology Solutions Corporation 
  • Oracle Corporation 
  • PAREXEL International Corporation 
  • PerkinElmer, Inc. 
  • SAS Institute Inc. 
  • UnitedHealth Group Incorporated 
  • Flatiron Health, Inc. 

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Real-world Data (RWD) Market:

  • In 2022, IQVIA, a prominent player in the life sciences industry, completed its acquisition of Enlight Analytics. This strategic move bolstered IQVIA's capabilities in Real-World Data (RWD) solutions, enhancing its position as a leading provider of services to the life sciences sector.
  • In 2021, PPD, Inc., which Thermo Fisher Scientific Inc. had acquired, made a significant acquisition of its own by adding Aetion to its portfolio. Action, known for its expertise in Real-World Data analytics and insights, brought valuable capabilities to PPD, further strengthening its offerings in data-driven solutions for the life sciences industry. This acquisition underscored Thermo Fisher's commitment to expanding its presence and influence in the healthcare and life sciences sectors.

The significant factors drive the market. The widespread adoption of (EHR)Electronic Health Record systems across healthcare organizations facilitates the collection and management of real-world data, providing a robust foundation for RWD analytics. Technological advancements in data analytics, machine learning, and artificial intelligence enable more sophisticated RWD analysis, unlocking valuable insights for research and decision-making, hence propelling market growth. The emphasis on evidence-based medicine and the need for real-world evidence (RWE) to complement clinical trial data drives the demand for RWD. It is particularly crucial for regulatory approvals and post-market surveillance. RWD is increasingly vital in drug development, from early-stage research to post-market studies. It is also becoming instrumental in market access strategies, reimbursement decisions, and health economic assessments. The shift towards patient-centered care encourages using RWD to understand better patient experiences, treatment outcomes, and healthcare utilization patterns.

However, Ensuring the quality and standardization of real-world data, which is often collected from diverse sources with varying accuracy and completeness, remains a significant challenge.  Many healthcare systems and data sources operate in silos, making integrating and analyzing data from different sources complex and restraining the market.

By Source

  • EMR/EHR/Clinical Data
  • Claims & Billing Data
  • Pharmacy Data
  • Product/Disease Registries Data
  • Genomics Data
  • Other Datasets

By Application

  • Market Access & Reimbursement/Coverage Decisions
  • Drug Development & Approvals
  • Oncology
  • Neurology
  • Immunology
  • Cardiovascular Diseases
  • Other Therapeutic Areas
  • Post-market Surveillance
  • Medical Device Development & Approvals
  • Regulatory and Clinical Decision-Making

By End User

  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Healthcare Payers
  • Healthcare Providers
  • Other End Users

By Region

  • Europe
  • North America
  • Asia Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the region's well-developed healthcare industry, the increasing prevalence of chronic illness, and the stringent regulations for drug approvals. Conversely, the European region is poised for substantial expansion in the forecast period due to the region's strong focus on innovation and the increasing adoption of big data in healthcare.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Real-world Data (Rwd) Market By Source, By Application, By End User, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction

    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology

    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary

    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  Real-world Data (Rwd) Market Variables, Trends & Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview

    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of Real-world Data (Rwd) Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  Real-world Data (Rwd) Market Analysis Tools

    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  Real-world Data (Rwd) Market, By Source Historical Analysis and Forecast 2024-2032 (USD Million)
      1. EMR/EHR/Clinical Data
      2. Claims & Billing Data
      3. Pharmacy Data
      4. Product/Disease Registries Data
      5. Genomics Data
      6. Other Datasets
         
  • 8.  Real-world Data (Rwd) Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Market Access & Reimbursement/Coverage Decisions
      2. Drug Development & Approvals
      3. Oncology
      4. Neurology
      5. Immunology
      6. Cardiovascular Diseases
      7. Other Therapeutic Areas
      8. Post-market Surveillance
      9. Medical Device Development & Approvals
      10. Regulatory and Clinical Decision-Making
         
  • 9.  Real-world Data (Rwd) Market, By End User Historical Analysis and Forecast 2024-2032 (USD Million)
      1. Pharmaceutical, Biotechnology, and Medical Device Companies
      2. Healthcare Payers
      3. Healthcare Providers
      4. Other End Users
         
  • 10.  North America Real-world Data (Rwd) Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 11.  Latin America Real-world Data (Rwd) Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 12.  Europe Real-world Data (Rwd) Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 13.  Asia Pacific Real-world Data (Rwd) Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 14.  Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 15.  Market Share Analysis and Competitive Landscape

    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)

    •   1. Anthem, Inc. (U.S.)
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. SWOT Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. IQVIA Holdings Inc. (U.S.)
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. SWOT Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. ICON plc (Ireland)
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. SWOT Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. PPD Inc. (U.S.)
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. SWOT Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. Clinigen Group plc (U.K.)
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. SWOT Analysis
           5.4. Financial Overview
           5.5. Strategic Overview
        6. Cognizant Technology Solutions Corporation (U.S.)
           6.1. Company Overview
           6.2. Product Portfolio
           6.3. SWOT Analysis
           6.4. Financial Overview
           6.5. Strategic Overview
        7. Oracle Corporation (U.S.)
           7.1. Company Overview
           7.2. Product Portfolio
           7.3. SWOT Analysis
           7.4. Financial Overview
           7.5. Strategic Overview
        8. PAREXEL International Corporation (U.S.)
           8.1. Company Overview
           8.2. Product Portfolio
           8.3. SWOT Analysis
           8.4. Financial Overview
           8.5. Strategic Overview
        9. PerkinElmer, Inc. (U.S.)
           9.1. Company Overview
           9.2. Product Portfolio
           9.3. SWOT Analysis
           9.4. Financial Overview
           9.5. Strategic Overview
        10. SAS Institute Inc. (U.S.)
           10.1. Company Overview
           10.2. Product Portfolio
           10.3. SWOT Analysis
           10.4. Financial Overview
           10.5. Strategic Overview
        11. UnitedHealth Group Incorporated (U.S.)
           11.1. Company Overview
           11.2. Product Portfolio
           11.3. SWOT Analysis
           11.4. Financial Overview
           11.5. Strategic Overview
        12. Flatiron Health, Inc. (U.S.)
           12.1. Company Overview
           12.2. Product Portfolio
           12.3. SWOT Analysis
           12.4. Financial Overview
           12.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact

    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
            administrations
        5. The overall economic slowdown of the developing and developed nations

  • 18.  FutureWise SME Key Takeaway Points for Client

    •   


Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11